John Kenneth Jenkins Corbus Pharmaceuticals Holdings, Inc. (CRBP) insider trading activity

John Kenneth Jenkins is of Corbus Pharmaceuticals Holdings, Inc.. Currently has a direct ownership of 2,816 shares of CRBP, which is worth approximately $48,153. The most recent transaction as insider was on May 30, 2024, when has been sold 2,783 shares (Common Stock, par value $0.0001 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).